What is the rate of response to non-operative treatment for hip-related pain? A systematic review with meta-analysis

Review written by Dr Joshua Heerey info

Key Points

  1. Half of all patients (54%) with hip-related pain responded to non-operative treatments.
All key points available for members only

BACKGROUND & OBJECTIVE

Hip-related pain is the recommended term to describe non-arthritic hip joint disease in young and middle-aged active adults (1). Hip-related pain can be further classified into three conditions: i) Femoroacetabular impingement (FAI) syndrome, ii) acetabular dysplasia and/or hip instability, and iii) other conditions without distinct osseous morphology, which can include labral, chondral, and ligamentum teres conditions (1).

Operative and non-operative treatments are used for patients with hip-related pain. Several recent studies have demonstrated the effectiveness of surgical approaches (e.g. hip arthroscopy) for hip-related pain (2,3). However, not all patients with hip-related pain are suitable for operative treatments. Developing suitable non-operative treatments and understanding patient response to such approaches is of utmost importance (4).

This systematic review and meta-analysis sought to: 1) determine the rate of satisfactory response to non-operative treatment for hip-related pain, 2) combine existing evidence regarding the specific effect of various elements of physical therapy, and 3) summarize evidence for nonoperative treatment options aside from physical therapy.

Developing suitable non-operative treatments and understanding patient response to such approaches is of utmost importance.
bulb
Clinicians should consider providing a comprehensive treatment approach in patients with hip-related pain that addresses biomechanical, biological, and psychosocial factors.

METHODS

  • The authors conducted a systematic review and meta-analysis, where they included randomized controlled trials and prospective cohort studies that evaluated non-operative treatments for hip-related pain.
to unlock full access to this review and 989 more